Activation of rat macrophages by Betafectin® PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3)

被引:46
作者
Michalek, M [1 ]
Melican, D [1 ]
Brunke-Reese, D [1 ]
Langevin, M [1 ]
Lemerise, K [1 ]
Galbraith, W [1 ]
Patchen, M [1 ]
Mackin, W [1 ]
机构
[1] Alpha Beta Technol Inc, Worcester, MA 01605 USA
关键词
beta-glucan; NR8383 cell line; respiratory burst; tumor necrosis factor alpha; CR3; receptor;
D O I
10.1002/jlb.64.3.337
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PGG-glucan (Betafectin(R)) is a soluble, highly purified yeast (1,3)-beta-glucan with broad anti-infective and immunomodulatory activities. These studies evaluated the ability of PGG-glucan to directly elicit O-2(-) and tumor necrosis factor alpha (TNF-alpha) production by rat leukocytes in vitro. Particulate beta-glucan stimulated O-2(-) production by the rat NR8383 alveolar macrophage cell Line and resident rat peritoneal macrophages, but soluble PGG-glucan did not. In contrast, presentation of PGG-glucan to cells after covalent immobilization to a plastic surface caused a direct stimulation of O-2(-) and TNF-alpha production. The O-2(-) response of rat leukocytes to immobilized PGG-glucan was inhibited by soluble PGG-glucan, indicating that cellular responses to both immobilized and soluble PGG-glucan occur via common cell surface receptors, Because complement receptor type three (CR3) has been proposed as a beta-glucan receptor on human leukocytes, NR8383 cells were evaluated for the presence of CR3, Indirect immunofluorescence and flow cytometric analysis showed that despite being responsive to both particulate and immobilized beta-glucans, NR8383 cells expressed no detectable CR3, These results indicate that the beta-glucan receptors on NR8383 cells are not CR3 and suggest that physical presentation plays an important role in inducing pro-inflammatory leukocyte responses to PGG-glucan.
引用
收藏
页码:337 / 344
页数:8
相关论文
共 67 条
[1]   STIMULATION OF HUMAN MONOCYTE BETA-GLUCAN RECEPTORS BY GLUCAN PARTICLES INDUCES PRODUCTION OF TNF-ALPHA AND IL-1-BETA [J].
ABEL, G ;
CZOP, JK .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (08) :1363-+
[2]   PGG-glucan activates NF-kappa B-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line [J].
Adams, DS ;
Pero, SC ;
Petro, JB ;
Nathans, R ;
Mackin, WM ;
Wakshull, E .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (06) :865-873
[3]  
AREND WP, 1985, J IMMUNOL, V134, P3868
[4]   RANDOMIZED PHASE I/II TRIAL OF A MACROPHAGE-SPECIFIC IMMUNOMODULATOR (PGG-GLUCAN) IN HIGH-RISK SURGICAL PATIENTS [J].
BABINEAU, TJ ;
MARCELLO, P ;
SWAILS, W ;
KENLER, A ;
BISTRIAN, B ;
FORSE, RA .
ANNALS OF SURGERY, 1994, 220 (05) :601-609
[5]  
BABINEAU TJ, 1994, ARCH SURG-CHICAGO, V129, P1204
[6]  
BLEICHER P, 1995, J BIOTECHNOL HEALTHC, V2, P207
[7]  
BOGWALD J, 1984, J LEUKOCYTE BIOL, V35, P357
[8]   (1->3)-beta-D-glucans as biological response modifiers: A review of structure-functional activity relationships [J].
Bohn, JA ;
BeMiller, JN .
CARBOHYDRATE POLYMERS, 1995, 28 (01) :3-14
[9]   ROLE OF COMPLEMENT RECEPTOR TYPE 3 AND SERUM OPSONINS IN THE NEUTROPHIL RESPONSE TO YEAST [J].
CAIN, JA ;
NEWMAN, SL ;
ROSS, GD .
COMPLEMENT, 1987, 4 (02) :75-86
[10]   MOLECULAR-BASIS OF CELL INTEGRITY AND MORPHOGENESIS IN SACCHAROMYCES-CEREVISIAE [J].
CID, VJ ;
DURAN, A ;
DELREY, F ;
SNYDER, MP ;
NOMBELA, C ;
SANCHEZ, M .
MICROBIOLOGICAL REVIEWS, 1995, 59 (03) :345-386